iPrEx, or Pre-Exposure Prophylaxis Initiative is a clinical trial aimed at determining whether two antiretroviral (ARV) medications used to treat HIV/AIDS help prevent HIV acquisition in HIV-uninfected people at high risk of infection.

Learn more

Press Release

FAQ

Fact Sheet

Join the Study

If you are interested in joining the study, click here and find out if there is a research site in your city.

What is new in iPrEx?